Carcinoma, Acinar Cell  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00101075: Title XELOX FOR SALIVARY GLAND CANCERS

Terminated
2
9
US
Capecitabine, Xeloda, Oxaliplatin, Eloxatin
Dana-Farber Cancer Institute, National Cancer Institute (NCI), Sanofi-Synthelabo
Head and Neck Cancer
03/07
03/08

Download Options